CYPRESS - CYPHER for Evaluating Sustained Safety

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Coronary Artery Disease

In brief

CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)

Key facts

Study ID

NCT00954707

Run by

Cordis US Corp.

People needed

2509

Starts

2009-08-01

Expected to finish

2016-03-01

Last updated by the study team

2014-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University Hospitals, Case Medical Center (Cleveland) — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.